Bringing the fundamentals into focus…
Back to Eupraxia Pharmaceuticals Inc.
How Eupraxia Pharmaceuticals Inc. stacks up
EPRX · against 435 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #278 of 436 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score159 peers with a valuation score of 0–9, including EPRX · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -16.3% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -8.5% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -8.4% vs peer median 0.0%
Metric by metric
Position: dot = EPRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | EPRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 422 reported | -14.8% | 0.4% | 22% | 30% | |
| EBITDA yieldHigher is better · 441 reported | -16.3% | 3.2% | 16% | 50% | |
| Free cash flow yieldHigher is better · 200 reported | -8.4% | -7.6% | 47% | 20% | |
| Book yieldHigher is better · 432 reported | 22.6% | 49.2% | 20% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around EPRX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 278 | 301M USD | 8 | ||
| 278 | 302M USD | 8 | 17 | |
| 278 | 530M USD | 8 | 23 | |
| 278 | 487M USD | 8 | 29 | |
| 278 | 455M USD | 8 | 36 | |
| 278 | 486M USD | 8 | 16 | |
| 278 | 551M USD | 8 | 27 | |
| 278 | 508M EUR (≈$559M) | 8 | 21 | |
| 278 | 660M USD | 8 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score